Screener
CONMED CNMD Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| authorized 500,000 shares; none outstanding | — | — |
| Common stock, par value $0.01 per share;100,000,000 shares authorized; 31,299,194 sharesissued in 2026 and 2025, respectively | 313 | 313 |
| Paid-in capital | 513,464 | 503,200 |
| Retained earnings | 625,665 | 588,766 |
| Accumulated other comprehensive loss | (43,372) | (46,295) |
| Less: 1,312,367 and 328,097 shares of common stock in treasury, at cost, in 2026 and 2025, respectively | (54,680) | (12,887) |
| Total shareholders’ equity | 1,041,390 | 1,033,097 |
| Total liabilities and shareholders’ equity | $2,300,306 | $2,325,749 |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's total equity?
- CONMED (CNMD) reported total equity of $1.04B in Q2 2026.
- How has CONMED's total equity changed year-over-year?
- CONMED's total equity increased by 3.8% year-over-year, from $1B to $1.04B.
- What is the long-term trend for CONMED's total equity?
- Over 5 years (2020 to 2025), CONMED's total equity has grown at a 7.8% compound annual growth rate (CAGR), from $709.04M to $1.03B.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about CONMED's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude